搜尋結果
Marijuana backers eye proposed federal regulatory change as an aid to legalizing pot in more states
Bastillepost· 2 日前As the U.S. government moves toward reclassifying marijuana as a less dangerous drug, there may ...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters· 3 日前, opens new tab on Thursday said it was very encouraged after completing an interim analysis of ...
Oh, Canada: U.S. Patients Don't Want Your Health Policies
Forbes· 7 日前There's never been a worse time to get sick in Canada. The Canadian government has chosen ...
WeightWatchers Struggles to Adapt Amid GLP-1 Drug Boom
Bloomberg· 1 日前Investors are waiting to see results from purchase of prescription service company
California Cuts Cost of Overdose-Reversal Drug by 40% in Generic Deal
Bloomberg· 6 日前California is stepping up efforts to combat surging opioid-related deaths by teaming with a ...
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg· 2 日前Have a confidential tip for our reporters? Novo Nordisk A/S shares fell as a US rival’s ...
The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy
Bloomberg· 5 日前There is no escaping Ozempic and Wegovy. The diabetes and obesity drugs are a global ...
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters· 3 日前, opens new tab missed Wall Street estimates for quarterly profit on Thursday, hurt by softer ...
Amgen scraps experimental weight loss pill, moves forward with injection
CNBC· 3 日前Amgen on Thursday said it will stop developing its experimental weight loss pill and instead ...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's ...
CNBC· 5 日前The Federal Trade Commission on Tuesday said it is challenging hundreds of alleged ...